Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roderick L Beijersbergen

Showing results (21-30 of 98) with videos related to

Pageof 10
Sort By:
Nature|April 15, 2026
Editorial Expression of Concern: Creation of human tumour cells with defined genetic elementsWilliam C Hahn, Christopher M Counter, Ante S Lundberg, et al.
Molecular Cancer Research : MCR|March 25, 2010
Interleukin-1R-associated kinase 2 is a novel modulator of the transforming growth factor beta signaling cascadeJasper Mullenders, Armida W M Fabius, Miranda M W van Dongen, et al.
Nature|January 28, 2012
Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFRAnirudh Prahallad, Chong Sun, Sidong Huang, et al.
Cell|June 18, 2005
A genetic screen identifies PITX1 as a suppressor of RAS activity and tumorigenicityIngrid G M Kolfschoten, Bart van Leeuwen, Katrien Berns, et al.
Nature Chemical Biology|February 14, 2006
An shRNA barcode screen provides insight into cancer cell vulnerability to MDM2 inhibitorsThijn R Brummelkamp, Armida W M Fabius, Jasper Mullenders, et al.
Cancer Research|May 31, 2018
Integrative Modeling Identifies Key Determinants of Inhibitor Sensitivity in Breast Cancer Cell LinesKatarzyna Jastrzebski, Bram Thijssen, Roelof J C Kluin, et al.
Molecular Cancer Research : MCR|June 23, 2021
Identification of Autophagy-Related Genes as Targets for Senescence Induction Using a Customizable CRISPR-Based Suicide Switch ScreenArnout Schepers, Fleur Jochems, Cor Lieftink, et al.
Gut|September 15, 2019
CDK12 inhibition mediates DNA damage and is synergistic with sorafenib treatment in hepatocellular carcinomaCun Wang, Hui Wang, Cor Lieftink, et al.
Molecular Cancer Therapeutics|May 20, 2016
Sensitizing Triple-Negative Breast Cancer to PI3K Inhibition by Cotargeting IGF1RKlaas de Lint, Jos B Poell, Hayssam Soueidan, et al.
Nature Communications|October 28, 2022
A doxycycline- and light-inducible Cre recombinase mouse model for optogenetic genome editingMiguel Vizoso, Colin E J Pritchard, Lorenzo Bombardelli, et al.
Pageof 10

Showing results (21-30 of 98) with videos related to

Sort By:
Pageof 10
Nature|April 15, 2026
Editorial Expression of Concern: Creation of human tumour cells with defined genetic elementsWilliam C Hahn, Christopher M Counter, Ante S Lundberg, et al.
Molecular Cancer Research : MCR|March 25, 2010
Interleukin-1R-associated kinase 2 is a novel modulator of the transforming growth factor beta signaling cascadeJasper Mullenders, Armida W M Fabius, Miranda M W van Dongen, et al.
Nature|January 28, 2012
Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFRAnirudh Prahallad, Chong Sun, Sidong Huang, et al.
Cell|June 18, 2005
A genetic screen identifies PITX1 as a suppressor of RAS activity and tumorigenicityIngrid G M Kolfschoten, Bart van Leeuwen, Katrien Berns, et al.
Nature Chemical Biology|February 14, 2006
An shRNA barcode screen provides insight into cancer cell vulnerability to MDM2 inhibitorsThijn R Brummelkamp, Armida W M Fabius, Jasper Mullenders, et al.
Cancer Research|May 31, 2018
Integrative Modeling Identifies Key Determinants of Inhibitor Sensitivity in Breast Cancer Cell LinesKatarzyna Jastrzebski, Bram Thijssen, Roelof J C Kluin, et al.
Molecular Cancer Research : MCR|June 23, 2021
Identification of Autophagy-Related Genes as Targets for Senescence Induction Using a Customizable CRISPR-Based Suicide Switch ScreenArnout Schepers, Fleur Jochems, Cor Lieftink, et al.
Gut|September 15, 2019
CDK12 inhibition mediates DNA damage and is synergistic with sorafenib treatment in hepatocellular carcinomaCun Wang, Hui Wang, Cor Lieftink, et al.
Molecular Cancer Therapeutics|May 20, 2016
Sensitizing Triple-Negative Breast Cancer to PI3K Inhibition by Cotargeting IGF1RKlaas de Lint, Jos B Poell, Hayssam Soueidan, et al.
Nature Communications|October 28, 2022
A doxycycline- and light-inducible Cre recombinase mouse model for optogenetic genome editingMiguel Vizoso, Colin E J Pritchard, Lorenzo Bombardelli, et al.
Pageof 10